Characterization of an induced pluripotent stem cell line NCHi011-A from a 23-year-old female with Alagille Syndrome harboring a heterozygous JAG1 pathogenic variant

Stem Cell Res. 2023 Oct:72:103213. doi: 10.1016/j.scr.2023.103213. Epub 2023 Sep 23.

Abstract

Alagille syndrome (ALGS) is a multisystem disease with high variability in clinical features. ALGS is predominantly caused by pathogenic variants in the Notch ligand JAG1. An iPSC line, NCHi011-A, was generated from a ALGS patient with complex cardiac phenotypes consisting of pulmonic valve and branch pulmonary artery stenosis. NCHi011-A is heterozygous for a single base duplication causing a frameshift in the JAG1 gene. This iPSC line demonstrates normal cellular morphology, expression of pluripotency markers, trilineage differentiation potential, and identity to the source patient. NCHi011-A provides a resource for modeling ALGS and investigating the role of Notch signaling in the disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alagille Syndrome* / genetics
  • Alagille Syndrome* / metabolism
  • Cell Differentiation
  • Female
  • Heart
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Jagged-1 Protein / genetics
  • Jagged-1 Protein / metabolism
  • Young Adult

Substances

  • Jagged-1 Protein
  • JAG1 protein, human